Kirsi Pylvänäinen

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

John Burn, Anne‐Marie Gerdes, Finlay Macrae et al. · The Lancet · 2011 · 951 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

Mev Dominguez–Valentin, Julian R. Sampson, Toni T. Seppälä et al. · Genetics in Medicine · 2019 · 649 citations · Full text

Medicine, Genetics, Oncology +17

Cancer risk and survival in <i>path_MMR</i> carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database

Pål Møller, Toni T. Seppälä, Inge Bernstein et al. · Gut · 2017 · 573 citations · Full text

Medicine, Oncology, Pathology +16

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database

Pål Møller, Toni T. Seppälä, Inge Bernstein et al. · Gut · 2015 · 545 citations · Full text

Medicine, Genetics, Oncology +17

Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial

John Burn, Harsh Sheth, Faye Elliott et al. · The Lancet · 2020 · 403 citations · Full text

Medicine, Pharmacotherapy, Preventive Medicine +16